NewsBig Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
More in Business
- ‘I’d rather be on a beach in Bali’: My husband resents my $8 million net worth. Should I pay for his retirement? MarketWatch
- Oil prices fall on report of potential diesel, crude stock release; Brent back below $100 CNBC — World News
- The Latest Challenge to Data Centers? Restive Investors. The New York Times — Business
- Gordon Ramsay’s UK restaurants stay in red despite sales topping £100m The Guardian — Business
- UAE terms FlyDubai flight incident a ‘terrorist act’, praises pilot Smit Machchhar Mint